Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

26.73
+0.49001.87%
Pre-market: 26.69-0.0400-0.15%06:44 EDT
Volume:54.34M
Turnover:1.45B
Market Cap:151.49B
PE:18.93
High:26.89
Open:26.40
Low:26.18
Close:26.24
Loading ...

Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
08 Feb

AbbVie Gets FDA Approval of Intravenous Antibiotic Emblaveo

Dow Jones
·
08 Feb

Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
07 Feb

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Feb

The Stock Rally Is Broadening. These S&P 500 Stocks Should Benefit. -- Barrons.com

Dow Jones
·
07 Feb

Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.

Blockhead
·
06 Feb

Daiwa Securities Adjusts Price Target on Pfizer to $30 From $28, Keeps Outperform Rating

MT Newswires Live
·
06 Feb

Pfizer Inc. Reports Q4 2024 Earnings: EPS of $0.63 and Revenue of $17.8 Billion, Both Surpassing Estimates

GuruFocus
·
06 Feb

Pfizer’s 2024 Earnings Call: Strong Performance and Strategic Growth

TIPRANKS
·
06 Feb

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Fortune
·
06 Feb

DZ BANK AG Sticks to Its Buy Rating for Pfizer (PFE)

TIPRANKS
·
06 Feb

MRNA, PFE, BNTX: Pharma Stocks Fall as RFK Jr. Set to Become U.S. Health Secretary

TIPRANKS
·
06 Feb

Ema: on 20 Jan, European Commission Withdrew Marketing Authorisation for Penbraya in EU

THOMSON REUTERS
·
05 Feb

BUZZ-Street View: All eyes on Pfizer's pipeline, obesity drug update

Reuters
·
05 Feb

TD Cowen Sticks to Their Hold Rating for Pfizer (PFE)

TIPRANKS
·
05 Feb

Pfizer Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
05 Feb